Continuity Biosciences Acquires Focal Medical to Enhance Targeted Drug Delivery for Pancreatic Cancer Continuity Biosciences has completed the acquisition of Focal Medical, a key step in advancing targeted therapies for inoperable solid tumors, notably pancreatic cancer.

Continuity Biosciences Acquires Focal Medical to Enhance Targeted Drug Delivery for Pancreatic Cancer #USA #pancreatic_cancer #Bradenton #Continuity_Biosciences #Focal_Medical

Continuity Biosciences Acquires Focal Medical to Enhance Pancreatic Cancer Treatment Continuity Biosciences has secured Focal Medical, enhancing their ability to deliver targeted therapies for pancreatic cancer through innovative drug delivery methods.

Continuity Biosciences Acquires Focal Medical to Enhance Pancreatic Cancer Treatment #USA #pancreatic_cancer #Bradenton #Continuity_Biosciences #Focal_Medical

Continuity Biosciences Acquires Focal Medical to Enhance Targeted Drug Delivery Innovations Continuity Biosciences has recently acquired Focal Medical, aiming to advance targeted drug delivery technologies. This strategic move focuses on better treatment options for pancreatic cancer patients.

Continuity Biosciences Acquires Focal Medical to Enhance Targeted Drug Delivery Innovations #USA #pancreatic_cancer #Bradenton #Continuity_Biosciences #Focal_Medical

Continuity Biosciences Executes Strategic Acquisition of Focal Medical to Enhance Targeted Drug Delivery for Pancreatic Cancer Continuity Biosciences has successfully acquired Focal Medical, aiming to revolutionize targeted drug delivery in pancreatic cancer treatment with innovative iontophoresis technology.

Continuity Biosciences Executes Strategic Acquisition of Focal Medical to Enhance Targeted Drug Delivery for Pancreatic Cancer #USA #pancreatic_cancer #Bradenton #Continuity_Biosciences #Focal_Medical